TY  - JOUR
AU  - Jessen, Frank
AU  - Wolfsgruber, Steffen
AU  - Kleineindam, Luca
AU  - Spottke, Annika
AU  - Altenstein, Slawek
AU  - Bartels, Claudia
AU  - Berger, Moritz
AU  - Brosseron, Frederic
AU  - Daamen, Marcel
AU  - Dichgans, Martin
AU  - Dobisch, Laura
AU  - Ewers, Michael
AU  - Fenski, Friederike
AU  - Fließbach, Klaus
AU  - Freiesleben, Silka Dawn
AU  - Glanz, Wenzel
AU  - Görß, Doreen
AU  - Gürsel, Selim
AU  - Janowitz, Daniel
AU  - Kilimann, Ingo
AU  - Kobeleva, Xenia
AU  - Lohse, Andrea
AU  - Maier, Franziska
AU  - Metzger, Coraline
AU  - Munk, Matthias
AU  - Preis, Lukas
AU  - Sanzenbacher, Carolin
AU  - Spruth, Eike Jakob
AU  - Rauchmann, Boris Stephan
AU  - Vukovich, Ruth C.
AU  - Yakupov, Renat
AU  - Weyrauch, Anne-Sophie
AU  - Ziegler, Gabriel
AU  - Schmid, Matthias
AU  - Laske, Christoph
AU  - Perneczky, Robert
AU  - Schneider, Anja
AU  - Wiltfang, Jens
AU  - Teipel, Stefan
AU  - Bürger, Katharina
AU  - Priller, Josef
AU  - Peters, Oliver
AU  - Ramirez, Alfredo
AU  - Boecker, Henning
AU  - Heneka, Michael T
AU  - Wagner, Michael
AU  - Düzel, Emrah
TI  - Subjective cognitive decline and stage 2 of Alzheimer disease in patients from memory centers.
JO  - Alzheimer's and dementia
VL  - 19
IS  - 2
SN  - 1552-5260
CY  - Hoboken, NJ
PB  - Wiley
M1  - DZNE-2022-00644
SP  - 487-497
PY  - 2023
N1  - (CC BY-NC-ND)
AB  - It is uncertain whether subjective cognitive decline (SCD) in individuals who seek medical help serves the identification of the initial symptomatic stage 2 of the Alzheimer's disease (AD) continuum.Cross-sectional and longitudinal data from the multicenter, memory clinic-based DELCODE study.The SCD group showed slightly worse cognition as well as more subtle functional and behavioral symptoms than the control group (CO). SCD-A+ cases (39.3
KW  - Humans
KW  - Alzheimer Disease: pathology
KW  - Amyloid beta-Peptides
KW  - Cross-Sectional Studies
KW  - Cognitive Dysfunction: diagnosis
KW  - Cognition
KW  - Biomarkers
KW  - tau Proteins
KW  - Alzheimer's disease (Other)
KW  - amyloid beta 42 (Other)
KW  - apolipoprotein E (Other)
KW  - cerebrospinal fluid (Other)
KW  - longitudinal (Other)
KW  - magnetic resonance imaging (Other)
KW  - mild cognitive impairment (Other)
KW  - positron emission tomography (Other)
KW  - subjective cognitive decline (Other)
KW  - tau (Other)
LB  - PUB:(DE-HGF)16
C6  - pmid:35451563
DO  - DOI:10.1002/alz.12674
UR  - https://pub.dzne.de/record/163975
ER  -